| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQT CORPORATION | 7 | Q2 2024 | 26.4% |
| OVID THERAPEUTICS INC | 7 | Q2 2024 | 20.5% |
| META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK | 7 | Q2 2024 | 13.4% |
| XOMA CORP COM | 7 | Q2 2024 | 13.1% |
| RANGE RESOURCES CORP | 7 | Q2 2024 | 8.1% |
| OMNIAB INC REG SHS COM | 7 | Q2 2024 | 6.9% |
| XENON PHARMS | 7 | Q2 2024 | 6.6% |
| ISHARES MSCI SINGAPORE ETF | 7 | Q2 2024 | 5.8% |
| HOVNANIAN ENTERPRISES INC COM | 7 | Q2 2024 | 2.0% |
| REGENERON PHARMACEUTICALS INC | 6 | Q2 2024 | 1.1% |
View TLS Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ovid Therapeutics Inc. | May 27, 2020 | 2,489,415 | 4.6% |
View TLS Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-28 |
| 13F-HR | 2024-08-07 |
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2020-05-27 |
| SC 13D/A | 2019-11-27 |
View TLS Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.